American Society of Clinical Oncology
martes, 22 de agosto de 2017
HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. | National Guideline Clearinghouse
<em>HER2</em> testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. | National Guideline Clearinghouse
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario